About Vinta Laboratories Private Limited
Data last updated: 21 February 2026
Vinta Laboratories Private Limited is a private limited company based in Rambilli Mandal, Andhra Pradesh, India, a subsidiary of Therazymes Private Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 12 July 2012, the company has been in operation for over 14 years.
Registered with ROC Vijayawada under CIN U24232AP2012PTC081966.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.71 Cr. Formerly known as Swaasa Pharma Limited. It is led by directors including Prakash Reddy Vinta and Neelima Mallu.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Plot No. 23 – D Apsez – Denotified Area Apiic, Rambilli Mandal, Andhra Pradesh, India – 531011.
As per the financials filed for FY 2021, the company reported a revenue of ₹67.23 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 159 employees as per the latest available data. It operates as a subsidiary of Therazymes Private Limited.
As per MCA filings, the company has open charges of ₹61.88 Cr and satisfied charges of ₹22.92 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website swaasapharma.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressPlot No. 23 – D Apsez – Denotified Area Apiic, Rambilli Mandal, Andhra Pradesh, India – 531011
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Vinta Laboratories Private Limited
Vinta Laboratories Private Limited has one previous CIN (Corporate Identification Number): U24232AP2012PLC081966. The current CIN is U24232AP2012PTC081966, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232AP2012PTC081966 | Current |
| U24232AP2012PLC081966 | Previous |
Business Activity of Vinta Laboratories Private Limited
Vinta Laboratories Private Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Manufacturing | ********* | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Vinta Laboratories Private Limited
Vinta Laboratories Private Limited is audited by ESWARAIAH & CO for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ESWARAIAH & CO | blur-value | blur-value | blur-value |
Board of Directors of Vinta Laboratories Private Limited
Vinta Laboratories Private Limited is currently managed by 6 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakash Reddy Vinta | Director | 22 Feb 2022 | 4 Years 4 Months | Current |
| Neelima Mallu | Director | 04 Sep 2019 | 6 Years 10 Months | Current |
|
Sreenivasulu Reddy Mallu
Also directs:
Therazymes Pharmaceuticals Private Limited, Therazymes Private Limited, Lakshmi Infra Projects Llp and 1 more
|
Director | 04 Sep 2019 | 6 Years 10 Months | Current |
| Dayakar Reddy Mallu | Director | 04 Sep 2019 | 6 Years 10 Months | Current |
|
Sashank Reddy Vinta
Also directs:
Vinta Labs Private Limited, Viplus Pharmaceuticals Private Limited, Care-Ind Chem Private Limited and 2 more
|
Director | 22 Feb 2022 | 4 Years 4 Months | Current |
Financials of Vinta Laboratories Private Limited FY 2024 filings available
Vinta Laboratories Private Limited reported revenue of ₹66.05 Cr (up 180.35% YoY) for FY 2021. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Vinta Laboratories Private Limited
As of FY 2021, Vinta Laboratories Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Vinta Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2023 | Others | ₹4 Cr | Open |
| 16 Sep 2023 | Others | ₹4 Cr | Open |
| 14 Sep 2023 | Others | ₹56.17 Lakh | Open |
| 08 Apr 2022 | Others | ₹3.02 Cr | Open |
| 30 Mar 2022 | Others | ₹14.73 Cr | Open |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Vinta Laboratories Private Limited
Vinta Laboratories Private Limited has a workforce of 159 employees as of Apr 06, 2024.
Employee Count & EPFO Data of Vinta Laboratories Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Vinta Laboratories Private Limited
GSTIN & GST Filing Data of Vinta Laboratories Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Vinta Laboratories Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Vinta Laboratories Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Vinta Laboratories Private Limited
MSME Payment Delays by Vinta Laboratories Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Vinta Laboratories Private Limited
Subsidiaries & Group Companies of Vinta Laboratories Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vinta Laboratories Private Limited with ownership details.
MCA Filings & Documents of Vinta Laboratories Private Limited
MCA Filings & Documents of Vinta Laboratories Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Vinta Laboratories Private Limited
Frequently Asked Questions about Vinta Laboratories Private Limited
Vinta Laboratories Private Limited is an active private limited company in the pharma sector based in Rambilli Mandal, Andhra Pradesh, India. It was incorporated on 12 July 2012 (14+ years old) and is registered under CIN U24232AP2012PTC081966. The company has 159 employees.
Vinta Laboratories Private Limited reported revenue of ₹67.23 Cr for FY 2021 (up 180.35% YoY).
The current directors of Vinta Laboratories Private Limited are:
The primary industry of Vinta Laboratories Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Vinta Laboratories Private Limited can be reached at the registered office: Plot No. 23 – D Apsez – Denotified Area Apiic, Rambilli Mandal, Andhra Pradesh, India – 531011, or through the website swaasapharma.com.
The authorised capital is ₹20 Cr, and the paid-up capital is ₹13.71 Cr.